AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Biopharm company announces start of clinical trial for HIV therapy.
2004 OCT 6 - (NewsRx.com & NewsRx.net) -- The Immune Response Corporation (IMNR), a biopharmaceutical company, announced the first patients have been enrolled at the Canadian site in its initial clinical trial investigating IR103, the company's newest product candidate in development for the treatment of HIV.
This trial, with active sites in the United Kingdom and Canada, will represent the first human experience with IR103, which combines the Company's patented HIV-1 Immunogen with Amplivax, an immunostimulatory oligonucleotide adjuvant.
The 2-part, 9-arm, randomized, single-blind, controlled, multi-center phase 1/2 study began this summer and will run for approximately 28 weeks with 80 patients enrolled. The primary ...
- The Immune Response Corporation Postpones Follow-on Public Offering of Common...
- Press release article from: PR Newswire August 7, 1996 700+ words
...PRNewswire/ -- The Immune Response Corporation (Nasdaq: IMNR) announced...executive officer of The Immune Response Corporation. "Immune Response has...less volatile." The Immune Response Corporation is a biopharmaceutical...
- Agouron and The Immune Response Corporation to Collaborate on Commercialization...
- Press release article from: PR Newswire June 11, 1998 700+ words
...Pharmaceuticals, Inc. (Nasdaq: AGPH) and The Immune Response Corporation (Immune Response) (Nasdaq: IMNR) today announced they...the National Institutes of Health. The Immune Response Corporation is a biopharmaceutical company based in...
- The Immune Response Corporation and NovaRx Corporation Announce Revision of...
- Press release article from: PR Newswire September 8, 2004 700+ words
The Immune Response Corporation , a biopharmaceutical company...agreement to transfer all of The Immune Response Corporation's in-licensed development...NovaRx agreed to pay The Immune Response Corporation the total sum of $1,050...
- The Immune Response Corporation to Present at Capital Growth Investor Forum.
- Press release article from: PR Newswire November 3, 2004 700+ words
The Immune Response Corporation , a biopharmaceutical company dedicated to becoming...Renaissance Hotel, Boca Raton, FL. About The Immune Response Corporation The Immune Response Corporation is a biopharmaceutical company dedicated to becoming...
- The Immune Response Corporation Presents Data at the International Congress of...
- Press release article from: PR Newswire July 27, 2004 700+ words
...Development on Track - The Immune Response Corporation , a biopharmaceutical...Executive Officer of The Immune Response Corporation. "The REMUNE(R...been licensed to The Immune Response Corporation. About The Immune Response...
- Immune Response Corporation Extends Exercise Date for Warrants.
- Press release article from: PR Newswire November 8, 2006 700+ words
...FirstCall/ -- The Immune Response Corporation (BULLETIN BOARD: IMNR...12,000,000 to The Immune Response Corporation. Other than the change...respects. About The Immune Response Corporation The Immune Response Corporation...
- The Immune Response Corporation Announces Clinical Trial for HIV Therapy IR103...
- Press release article from: PR Newswire September 10, 2004 700+ words
...International Trial The Immune Response Corporation , a biopharmaceutical...Executive Officer of The Immune Response Corporation. "Further, the UK...trial please contact The Immune Response Corporation at 760-431-7080 in...
- The Immune Response Corporation Presents New Phase II Clinical Data Indicating...
- Press release article from: PR Newswire September 14, 2004 700+ words
...being developed by The Immune Response Corporation , a biopharmaceutical...Executive Officer of The Immune Response Corporation. "With guidelines recommending...Clinical Development at The Immune Response Corporation. "We are looking forward...